Inhibition of cataracts in moderately diabetic rats by aminoguanidine

Experimental Eye Research

Volumn 62, Issue 5, 1996, Pages 505-510

  Swamy Mruthinti, S ^a   Green, K ^a   Abraham, E C ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

AGEs; Aminoguanidine; Diabetic cataract; Glycation; Scheimpflug slit image analysis

Indexed keywords

AMINOGUANIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATARACT; CATARACTOGENESIS; CONTROLLED STUDY; DIABETES MELLITUS; GLYCATION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029893678     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.1996.0061     Document Type: Article

References (24)

1. Abraham, E. C., Abraham, A. and Swamy-Mruthinti, S. (1993). Does the advanced glycation mediated protein cross-linking play a predominant role in the development of cataract in diabetic rat model. International Cooperative Cataract Research Group Congress, Bethesda, MD.
2. Beswick, H. T. and Harding, J. J. (1987). Conformational changes induced in lens α-and γ-crystallins by modification with glucose-6-phosphate. Biochem. J. 246, 761-9.
3. Bhuyan, K. C. and Bhuyan, K. D. (1984). Molecular mechanisms of cataractogenesis. III. Toxic metabolites of oxygen as initiators of lipid peroxidation and cataract. Curr. Eye Res. 3, 67-81.
4. Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P. and Cerami, A. (1986). Aminoguanidine prevents diabetes induced arterial wall protein cross linking. Science 232, 1629-32.
5. Chen, H. J. C. and Cerami, A. (1993). Mechanism of inhibition of advanced glycosylation by aminoguanidine in vitro. J. Carb. Chem. 12, 731-42.
6. Chibber, R., Molinatii, P. A., Wong, J. S. K., Mirlees, D. and Kohner, E. M. (1994). The effect of aminoguanidine and tolrestat on glucose toxicity in bovine retinal capillary pericytes. Diabetes 43, 758-63.
7. Ellis, E. N. and Bowen, W. (1990). Aminoguanidine ameliorates glomerular basement membrane (GBM) thickening in experimental diabetes. Diabetes 39 (Suppl.), 71A.
8. Hammes, P. H., Martin, S., Ferderlin, K., Gelsen, K. and Brownlee, M. (1991). Aminoguanidine inhibits the development of experimental diabetic retinopathy. Proc. Natl. Acad. Sci., USA 88, 11555-8.
9. Horiuchi, S., Araki, N. and Morino, Y. (1991). Immunological approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure. J. Biol. Chem. 266, 7329-32.
10. Hunt, J. V., Dean, R. T. and Wolff, S. P. C. (1988). Hydroxyl radical production and autoxidative glycosylation: Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem. J. 256, 205-12.
11. Jerums, G. (1993). In vivo effects of aminoguanidine. Paper 48, 5th International Symposium Maillard Reaction, St. Paul, MN, August-September, 1993.
12. Kumari, K., Umar, S., Bansal, V. and Sahib, M. K. (1991). Inhibition of diabetes associated complications by nucleophilic compounds. Diabetes 40, 1079-84.
13. Liang, J. N. and Chylack, L. T., Jr. (1984). Change in the protein tertiary structure with nonenzymic glycation in human α-crystallin. Biochem. Biophys. Res. Commun. 124, 899-906.
14. Lowry, O. H., Roseborough, N. J., Farr, A. L. and Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-75.
15. Monnier, V. M. and Cerami, A. (1981). Non-enzymatic browning in vivo: possible process for aging of long-lived proteins. Science 211, 491-3.
16. Nakayama, H., Mitsuhashi, T., Kuwajima, S., Aoki, S., Kuroda, Y., Itoh, T. and Nakagawa, S. (1993). Immunochemical detection of advanced glycation end products in lens crystallins from streptozotocin-induced diabetic rat. Diabetes 42, 345-50.
17. Perry, R. E., Swamy, M. S. and Abraham, E. C. (1987). Progressive changes in lens crystallin glycation and high-molecular-weight aggregate formation leading to cataract development in streptozotocin-diabetic rats. Exp. Eye Res. 44, 269-82.
18. Stevens, V. J., Rouzer, C. A., Monnier, V. M. and Cerami, A. (1978). Diabetic cataract formation: Potential role of glycosylation of lens crystallins. Proc. Natl. Acad. Sci., USA 75, 2918-22.
19. Swamy, M. S. and Abraham, E. C. (1989). Lens protein composition, glycation and high molecular weight aggregation in aging rats. Invest. Ophthalmol. Vis. Sci. 28, 1693-701.
20. Swamy, M. S., Tsai, C., Abraham, A. and Abraham, E. C. (1993). Glycation mediated lens crystallin aggregation and cross-linking by various sugars and sugar phosphate in vitro. Exp. Eye Res. 56, 177-85.
21. Swamy-Mruthinti, S., Green, K. and Abraham, E. C. Scheimpflug densitometric analysis of cataracts in diabetic rats: Correlation with glycation. Ophthalmic Res. (submitted).
22. Tilton, R. G., Chang, K., Hasan, K. S., Smith, S. R., Petrash, J. M., Misko, T. P., Moore, W. M., Currie, M. G., Corbett, J. A., McDaniel, M. L. and Williamson, J. R. (1993). Prevention of diabetic vascular dysfunction by guanidines : inhibition of nitric oxide synthase versus advanced-glycation end-product formation. Diabetes 42, 221-32.
23. Williamson, J. R., Chang, K., Ido, Y., Ostrow, E., Allison, W., Harlow, J. and Tilton, R. G. (1990). Aminoguanidine prevents diabetes (streptozotocin) induced increase in vascular albumin permeation of rat sciatic nerve. Diabetes Metab. Rev. 16, 369-70.
24. Yagihashi, S., Kamijo, M., Baba, M. and Nagai, K. (1992). Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes 41, 47-52.